News for hackers. Stuff that matters.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by trgv on Friday October 13, 2017 @10:26PM (#15470340)
Assuming that psilocybin is effective at treating depression, I find myself wondering whether actual conscious experience (that is, being high) is an essential part of its effectiveness or not.

To put this another way, imagine someone takes whatever dose of psilocybin and then is rendered unconsciousness until the perceptual effects wear off. Will there be any difference in its effectiveness as a treatment for depression?

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by delegate on Saturday October 14, 2017 @07:44AM (#15471743)
Being conscious during the trip is an essential part of the healing process. In fact, healing comes from the realization of what consciousness really is, that death is not the end, how my little self is just a stubborn part of a larger infinite consciousness that is the Universe thinking itself into existence, etc. You 'remember' what you really are and that's liberating.

One theory that I subscribe to is that the drug increases the brain's neuroplasticity, allowing for new pathways to be created between sometimes unrelated parts of the brain.

Being conscious allows one to guide (but not control heh) this process, where the user can pick a subject to think about and immerse oneself into a audiovisual/emotional/cognitive hallucinatory experience that follows related to that subject. Inevitably the most pressing issues of one's life will surface, allowing the user to examine them from all these different angles - accept, forgive, love and heal.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by CuriouslyC on Saturday October 14, 2017 @09:49AM (#15472152)
Psychedelics absolutely increase neuroplasticity, via triggering the release of BDNF. They are also extremely potent anti-inflammatories.

Regarding the value of the trip itself, you pretty much hit the nail on the head. It always makes me chuckle when scientists talk about trying to isolate the antidepressant effect from the psychedelic nature of the experience. That is a sure sign that the people studying the compound lack significant first-hand experience with it.

[dead]
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by indiv0 on Saturday October 14, 2017 @09:33PM (#15475373)
To be fair, these realizations are a commonly reported effect of psychoactive drugs. They are common, and the realizations are strong enough that the participants occasionally internalize those ideas.

Whether or not they're true objectively doesn't really matter if the participants believe them to be true.

If they believe those ideas to be true, and that belief is what causes the improvement (similar to how "finding religion" helps people), is that not enough?

Although I do agree that obviously just because they've internalized this experience, that doesn't make it objectively true.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by louithethrid on Sunday October 15, 2017 @04:53AM (#15476428)
Oh, so its all git-versioned, our brains just returns to the soup of what we came frame? No risks at all? Not a chance, that somebody could simply mistake a deactivated body experience/ out of body experience with a thinking universe?
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by _jal on Saturday October 14, 2017 @10:42PM (#15475594)
Consider it a neurochemical hack that reliably induces certain perceptual shifts. Those shifts in turn can help stabilize various emotional disequilibria.

Does that make it more palatable?

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by meowface on Saturday October 14, 2017 @10:59PM (#15475655)
The parent post was answering a difficult question with nothing other than their personal feeling about it. They have absolutely no evidence that it wouldn't have the same anti-depressant effects if someone was unconscious during their trip.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by _jal on Monday October 16, 2017 @12:02PM (#15484196)
I absolutely agree with everything you said. I still find it to be a valid accounting of their own internal observations; the fact that it is subjective and not subject to external validation doesn't mean it is useless, it just means you're not extracting particular results from it that you apparently desire.

There are ways of knowing things that cannot be externally validated. That doesn't mean you can't study them within the four corners of the scientific method; we study pain, depression and lots of other things that take place in the head, too, and a big part of the input is "feelings".

But even without scientific rigor, we can know things. I don't need a study to know when to eat, and I know I've undergone perceptual shifts for various reasons. Since I'm not leading a policy crusade for legalization, a PR campaign to change public perception of legalization or a company that just really wants to sell mushrooms, I don't need more certainty.

TL;DR: there are different ways of knowing things that are good for different purposes.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by anythingnonidin on Saturday October 14, 2017 @03:15AM (#15471146)
I believe we already have an answer for this - which is that most of the benefits of psilocybin on depression (and most other things) rely on the patient being conscious so that they are able to have a 'mystical-type experience.'

In almost all psilocybin studies, the effect is mediated by the degree to which the participant has a 'mystical-type experience.'

I don't imagine this could be experienced while unconscious, and so assuming that's correct, then it would be substantially less effective if someone was unconscious.

I would expect a small anti-depressant effect of psilocybin alone, possibly related to the serotonin 2A receptor and it's impact on well-being. But, to be very clear - the active experience of a 'mystical trip' is what causes a reduction in depression.

See:

http://journals.sagepub.com/doi/full/10.1177/026988111773127...

'Determinants of enduring effects were psilocybin-occasioned mystical-type experience'

http://journals.sagepub.com/doi/full/10.1177/026988111667551...

'The psilocybin-induced mystical experience mediated the therapeutic effect of psilocybin on anxiety and depression.'

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by derefr on Saturday October 14, 2017 @03:36AM (#15471189)
On the other hand, apparently electro-convulsive therapy still has an antidepressant effect even when patients are anesthetized for the treatment. So it's not like this is a dumb question to ask categorically.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by anythingnonidin on Saturday October 14, 2017 @03:53AM (#15471220)
Absolutely not a dumb question to ask, thanks for noting that. In fact, a really good question to ask, as like some other commenters noted that would actually be nice and convenient if it was the case. I just wanted to make sure the information was available on what we know, as I think research has already found the answer, to anyone who viewed the thread.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by beagle3 on Saturday October 14, 2017 @07:58AM (#15471777)
> In almost all psilocybin studies, the effect is mediated by the degree to which the participant has a 'mystical-type experience.'

> I don't imagine this could be experienced while unconscious, and so assuming that's correct, then it would be substantially less effective if someone was unconscious.

It's correlation, but to determine causation one would have to undergo simultaneous mystical-inducing-quantity psilocybin and be "naturally" unconscious (because e.g. stuff used for general anesthesia is likely to interfere with other brain processes). I have no idea how such an experiment could actually be carried out.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by filoeleven on Sunday October 15, 2017 @12:42PM (#15477894)
Overnight hospital stay with an IV drip to administer the psilocybin after the patient falls asleep?
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by beagle3 on Monday October 16, 2017 @02:09AM (#15481204)
Sounds like a good idea, provided that the patient is a good sleeper and is not sleep deprived - there is research showing sleep deprivation provides some short term relief for depression ... everything is confounding, nothing is intuitive about these things.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by mabbo on Friday October 13, 2017 @10:49PM (#15470412)
To refine your question further[0]: is this an effect of the psychological experience of tripping on mushrooms, or is this a physiological effect of the drug itself?

In either case, it may explain some habitual drugs users who are actually self-medicating. It could be that in a few years, they're doing the exact same thing but with a prescription to make it all morally upstanding.

[0]Correct me if I'm misunderstanding.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by NegativeLatency on Friday October 13, 2017 @11:46PM (#15470606)
In regard to you second part, that has happened/is happening in the US on a state by state basis with marijuana.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by drvdevd on Saturday October 14, 2017 @02:37AM (#15471069)
I’m not going to look for references right now, but there is current research into the anti-inflammatory effects of classical psychedelics.

Anecdotally, it has been speculated by researchers that it is in fact this effect that produces many of the observed benefits, apart from the psychedelic experience itself.

And so people are looking at analogs that can have some of the same receptor affinity profiles without causing psychedelic effects, or with much diminished psychedelic effects.

Personally I think a protocol such as what you suggest is a better approach and would work.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by heavenlyblue on Saturday October 14, 2017 @09:44AM (#15472132)
I had a friend who had a historical condition caused by a spinal trauma in her childhood, while professionally practicing ballet.

It would be externalised as random pains associated with her back.

She went through several prescription painkillers when her doctor told her to try sub-recreational doses of shrooms to treat the pain (obviously not prescribed).

It worked well until I believe she tripped hard, which I suppose happens with street-quality drugs and specifically with mushrooms which if not extracted have a relatively large variablity in concentrations between mushrooms bodies.

So here's both the lesson of why she stopped doing them and the obvious fact of some doctors actually knowing of the effects; but they can not advise since there no specific research on this could be used as a medication this and whether that could even be regularly prescribed as a medicine.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by gwern on Saturday October 14, 2017 @09:53AM (#15472171)
I believe the ketamine anti-depressant experiments use a different anesthetic to put subjects under in order to split the trip experience from the lower-level chemical effects, and still find benefits. If the trip itself is not necessary for ketamine, that makes it more plausible that it's not necessary for psilocybin etc.

(Of course, this doesn't rule out the possibility that much of the benefit is coming from after the trip during regular life based on experiencing regular life with 'reset' neurons under the Carhart-Harris/Nutt interpretation.)

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by bramen on Saturday October 14, 2017 @03:28PM (#15473754)
The experiments I've read about don't use any additional anaesthetic. They just give people a low but still noticeable dose intravenously. Some people reported mild and transient unpleasantness during the treatment due to the drug's effects.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by amigoingtodie on Saturday October 14, 2017 @10:43AM (#15472366)
Ketamine is used as a disassociative, though.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by pizza on Saturday October 14, 2017 @08:47PM (#15475191)
The categories aren't necessarily as clear cut as label -> effect, though, as in psychedelics (including psilocybin and its relatives) can be dissociating, and ketamine (and other dissociatives) can be psychedelic. That said, not because of particularly similar physiology; they certainly have different receptor targets.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by notduncansmith on Saturday October 14, 2017 @02:04AM (#15471013)
Doubtful, but I'm sure you could find a way if you really tried, maybe with someone to talk to you while you sleep.

Euphoria is only one of several effects on the consciousness, and in many cases the deliberate cognitive processes that are enabled/invited by that combination of effects are the real treatment. This is when the issues causing the depression are thought patterns, which can sometimes be more effectively examined and dealt with under the influence of ego-fear-dissolving euphoria, dissociativity, form constant hallucinations, etc.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by monktastic1 on Saturday October 14, 2017 @08:18PM (#15475093)
There's good evidence that the degree to which a person has a "mystical-type experience" is a good predictor of the benefit.

This is not surprising if you've taken it before. It's the experience itself that's liberating, much in the same way that other profoundly meaningful experiences in life depend on you actually "being there" to have any benefit.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by anythingnonidin on Saturday October 14, 2017 @10:53PM (#15475632)
Yep, this. See my reply to the poster for more info.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by WalterSear on Saturday October 14, 2017 @01:16AM (#15470895)
The effects of subthreshold doses of psilocybine would suggest that it's a cause of the drug, rather than the experience.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by glorifirdious on Friday October 13, 2017 @10:49PM (#15470414)
Yes, it would still work because the current hypothesis is that it's the resulting increase in neurogenesis which is responsible for the amelioration of depression.

Neurogenesis in general seems to be inversely proportional to experiences of depression.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by Xenograph on Friday October 13, 2017 @11:43PM (#15470594)
That's assuming that the same neurogenesis still happens in the absence of a conscious experience. Do you have evidence that supports this?
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by anythingnonidin on Saturday October 14, 2017 @03:17AM (#15471148)
Nope, the effect is mediated by the psilocybin induced mystical experience, which I don't believe could be experienced while unconscious. See my comment above.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by md224 on Friday October 13, 2017 @11:54PM (#15470637)
Great question. Would love to see controlled studies on this, though the anaesthetic drug would be a confounding factor.

That makes me wonder: what if we gave people psilocybin and knocked them out with ketamine until the effects subsided? Hmm...

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by uoaei on Saturday October 14, 2017 @01:05AM (#15470870)
I'm not sure if your question was tongue-in-cheek, but a k-hole (high ketamine dose) is also considered by some to be a psychedelic experience. It was (is?) common in the rave culture to do exactly what you describe.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by evincarofautumn on Friday October 13, 2017 @10:41PM (#15470392)
I would assume so, that it’d be akin to a strong one-shot antidepressant. Psilocybin is quickly metabolised to psilocin, which binds to serotonin receptors. It might be more of a risk for a bad trip, though, unless you have good dream control.

Also, you’d definitely need to be rendered unconscious, haha—I can’t imagine trying to sleep naturally on mushrooms, although when I take them I always have the most beautifully restful sleep after coming down.

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by DigitalJack on Friday October 13, 2017 @10:57PM (#15470438)
Propofol would do the trick (in a clinical setting).
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by SomeStupidPoint on Friday October 13, 2017 @11:52PM (#15470622)
Putting someone under while on drugs that typically render it hard to sleep without disrupting the drugs seems considerably harder and riskier than keeping the trip a safe experience by having experienced psychiatrists and antipsychs on hand.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by amigoingtodie on Saturday October 14, 2017 @10:47AM (#15472382)
Michael Jackson disagrees.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by ssijak on Saturday October 14, 2017 @02:37AM (#15471070)
Hallucinacions are part of the healing with any psychedelic for me. Set yourself in a pleasant environment with cool people, and the experience that you get will be long lasting and behavior changing. Not always life changing, but it always added something positive to my views, thinking or overall scence of wellbeing. At it is the same for mushrooms, lsd and ayahuasca
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by hwillis on Saturday October 14, 2017 @01:44AM (#15470962)
Serotonin and brain function: a tale of two receptors by Robin Carhart-Harris and David Nutt[1] suggests that the main affects are due to the conscious impacts on behavior, but that those impacts don't depend on the experience of being high so much as the long-lasting effects of the stimulation. It basically comes down to whether or not you believe them though.

[1] http://slatestarcodex.com/2017/10/10/ssc-journal-club-seroto...

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by jonnycomputer on Saturday October 14, 2017 @12:18PM (#15472817)
well, in these studies, we are talking about really low doses. so no, "trip"
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by adrice727 on Saturday October 14, 2017 @12:58PM (#15473014)

  The present study focused on changes in brain function before versus after psilocybin in 
  patients with treatment-resistant depression who received two doses of the drug 
  (10 mg followed by 25 mg, one-week apart) as part of an open-label clinical trial.
25mg of pure psilocybin, the equivalent of 3.3 - 5 grams of dried mushrooms (depending on strength), is certainly enough for a trip.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by pizza on Saturday October 14, 2017 @08:48PM (#15475199)
It would be interesting to see if pure psilocybin (or prodrugs thereof) elicited as similarly-successful a response. I wonder to what extent other alkaloids, that are also present in mushrooms, affect the after-effects crucial to anti-depression.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by amigoingtodie on Saturday October 14, 2017 @10:42AM (#15472356)
The introspection is crucial.
Re:Psilocybin for treatment-resistant depression: fMRI-measu... by dguaraglia on Saturday October 14, 2017 @06:03PM (#15474585)
I guess what the parent comment was questioning was exactly this assertion. I tend to believe that the introspection is part of the reason these drugs help, but we won't really know for a fact until proper double blind experiments are done.